Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$51.37

0.34 (0.67%)

07:14
02/27/18
02/27
07:14
02/27/18
07:14

Ionis Pharmaceuticals sees FY18 R&D expenses of $360M-$390M

The company said "2017 was our first year of commercial revenue in which we earned $113M in SPINRAZA royalties. It was also our sixth consecutive year of revenue growth, driven by our focus on high-value, innovative drugs like SPINRAZA and multiple other exciting programs in our pipeline. Our goal is to be a multi-product, sustainably profitable company. Consistent with this goal, we project 2018 will be our third consecutive year of pro forma operating profitability even as we prepare to launch two new drugs. For 2018, we are projecting R&D expenses of $360M-$390M and SG&A expenses of $180M-$210M both on a pro forma basis. We project that we will end 2018 with more than $800M in cash."

  • 27

    Feb

  • 06

    Jul

IONS Ionis Pharmaceuticals
$51.37

0.34 (0.67%)

11/02/17
RILY
11/02/17
NO CHANGE
Target $240
RILY
Buy
Alnylam price target raised to $240 from $150 at B. Riley FBR
After Alnylam (ALNY) presented complete results from the Phase III APOLLO trial of patisiran in hereditary TTR amyloidosis with polyneuropathy, B. Riley FBR analyst Madhu Kumar said the results demonstrate a "clear advantage on both efficacy and safety" over Ionis Pharmaceuticals' (IONS) inotsersen. Kumar raised his price target on Alnylam to $240 from $150 following the data and keeps a Buy rating on the stock.
11/03/17
WELS
11/03/17
NO CHANGE
Target $113
WELS
Outperform
Ionis pullback yesterday a buying opportunity, says Wells Fargo
Wells Fargo analyst Jim Birchenough recommends using the 10% pullback yesterday in shares of Ionis Pharmaceuticals (IONS) as a buying opportunity. Ionis now trades at roughly half the valuation of Alnylam (ALNY), and with both companies having full global rights to their TTR amyloidosis drugs, a review of aggregate value suggests "significant upside potential" for Ionis shares, Birchenough tells investors in a research note. The analyst keeps an Outperform rating on the shares with a $113 price target.
11/15/17
LEER
11/15/17
NO CHANGE
Target $53
LEER
Outperform
Wave Life Sciences price target raised to $53 from $42 at Leerink
Leerink analyst Paul Matteis raised his price target for Wave Life Sciences to $53 from $42, while reiterating an Outperform rating on the shares, as his research has rendered him more optimistic on emerging Huntington's Disease drug candidates from Ionis Pharmaceuticals (IONS) and Wave Life Sciences. The analyst also raised his price target for Ionis to $58 from $54.
02/20/18
BERN
02/20/18
NO CHANGE
Target $55
BERN
Market Perform
Ionis Pharmaceuticals price target lowered to $55 from $61 at Bernstein
Bernstein analyst Vincent Chen lowered his price target for Ionis Pharmaceuticals to $55 from $61 reflecting what is likely to be a faster decline in Spinraza sales trajectory than he had previously modeled. The analyst reiterates a Market Perform rating on the shares.

TODAY'S FREE FLY STORIES

PZZA

Papa John's

$51.43

-2.04 (-3.82%)

17:41
07/16/18
07/16
17:41
07/16/18
17:41
Periodicals
Papa John's founder regrets stepping down as chairman, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GLD

SPDR Gold Trust

$117.55

-0.045 (-0.04%)

17:36
07/16/18
07/16
17:36
07/16/18
17:36
Hot Stocks
SPDR Gold Trust holdings fall to 794.01MT from 795.19MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$51.87

-1.06 (-2.00%)

17:29
07/16/18
07/16
17:29
07/16/18
17:29
Hot Stocks
Maxar's MDA acquires Neptec Design Group for C$42M »

MDA, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$136.21

-0.99 (-0.72%)

17:29
07/16/18
07/16
17:29
07/16/18
17:29
Syndicate
Breaking Syndicate news story on Autodesk »

Autodesk files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$58.83

-0.18 (-0.31%)

17:28
07/16/18
07/16
17:28
07/16/18
17:28
Hot Stocks
Showtime: Cohen did not present self as disabled veteran in 'Who is America?' »

CBS' Showtime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 09

    Aug

  • 06

    Sep

KTOV

Kitov Pharmaceuticals

$2.22

-0.13 (-5.53%)

17:27
07/16/18
07/16
17:27
07/16/18
17:27
Syndicate
Kitov Pharmaceuticals files to sell 2.56M American Depositary Shares »

Each representing 20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

17:22
07/16/18
07/16
17:22
07/16/18
17:22
Hot Stocks
Amazon says 'some customers are having difficulty shopping' on Prime Day »

In a posting to its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

FAF

First American

$51.89

0.02 (0.04%)

, FNF

Fidelity National

$37.23

0.14 (0.38%)

17:21
07/16/18
07/16
17:21
07/16/18
17:21
Upgrade
First American, Fidelity National rating change  »

First American upgraded…

FAF

First American

$51.89

0.02 (0.04%)

FNF

Fidelity National

$37.23

0.14 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

NAKD

Naked Brand Group

$4.95

-0.15 (-2.94%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Syndicate
Breaking Syndicate news story on Naked Brand Group »

Naked Brand Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

Fidelity National

$37.23

0.14 (0.38%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Upgrade
Fidelity National rating change  »

Fidelity National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

LMT

Lockheed Martin

$319.13

0.69 (0.22%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Hot Stocks
Lockheed Martin awarded $450.7M U.S. Navy contract modification »

Lockheed Martin awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

FDEF

First Defiance Financial

$33.61

1.005 (3.08%)

17:18
07/16/18
07/16
17:18
07/16/18
17:18
Earnings
First Defiance Financial reports Q2 adjusted EPS 54c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 31

    Jul

LNT

Alliant Energy

$42.79

-0.14 (-0.33%)

17:05
07/16/18
07/16
17:05
07/16/18
17:05
Hot Stocks
Alliant Energy announces 210MW wind farm in Iowa »

Iowa customers and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TRQ

Turquoise Hill

$2.94

0.11 (3.89%)

17:02
07/16/18
07/16
17:02
07/16/18
17:02
Hot Stocks
Turquoise Hill reports Q2 throughput production up 6.3% from Q1 »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$2.85

-0.055 (-1.90%)

17:02
07/16/18
07/16
17:02
07/16/18
17:02
Syndicate
Breaking Syndicate news story on Aveo Pharmaceuticals »

Aveo Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
07/16/18
07/16
16:55
07/16/18
16:55
Conference/Events
Morgan Stanleey econo »

Australian Economist…

RIG

Transocean

$13.10

-0.37 (-2.75%)

16:42
07/16/18
07/16
16:42
07/16/18
16:42
Hot Stocks
Transocean announces $75M 13-well contract for Transocean 712 »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

AG

First Majestic

$7.44

-0.265 (-3.44%)

16:40
07/16/18
07/16
16:40
07/16/18
16:40
Hot Stocks
First Majestic raises 2018 CapEx view to $148.7M from $125.4M »

First Majestic has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLY

Ally Financial

$27.24

-0.09 (-0.33%)

16:39
07/16/18
07/16
16:39
07/16/18
16:39
Hot Stocks
Ally Financial raises quarterly dividend to 15c from 13c per share »

Payable on August 15 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

OSG

Overseas Shipholding

$3.51

-0.125 (-3.44%)

16:38
07/16/18
07/16
16:38
07/16/18
16:38
Hot Stocks
Overseas Shipholding signs contract with HMD for two chemical tankers »

Overseas Shipholding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AG

First Majestic

$7.44

-0.265 (-3.44%)

16:38
07/16/18
07/16
16:38
07/16/18
16:38
Hot Stocks
First Majestic reports Q2 production 5.1M Ag eq oz., raises 2018 guidance »

First Majestic reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHDN

Churchill Downs

$303.50

0.05 (0.02%)

16:35
07/16/18
07/16
16:35
07/16/18
16:35
Hot Stocks
Churchill Downs to acquire remaining 50% ownership of Ocean Downs »

Churchill Downs, or CDI,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

BAC

Bank of America

$29.77

1.235 (4.33%)

, DB

Deutsche Bank

$12.14

0.9 (8.01%)

16:33
07/16/18
07/16
16:33
07/16/18
16:33
General news
Fly Intel: Wall Street's top stories for Monday »

Stocks drifted throughout…

BAC

Bank of America

$29.77

1.235 (4.33%)

DB

Deutsche Bank

$12.14

0.9 (8.01%)

TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

BHC

Bausch Health

$23.01

-0.39 (-1.67%)

VRX

Valeant

$0.00

(0.00%)

ARNC

Arconic

$19.19

1.8 (10.35%)

APO

Apollo Global

$35.90

-0.23 (-0.64%)

AMD

AMD

$16.58

0.305 (1.87%)

OSUR

OraSure

$16.28

-1.04 (-6.00%)

NTLA

Intellia Therapeutics

$29.37

-3.23 (-9.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Aug

  • 06

    Sep

NVCN

Neovasc

$0.04

-0.0004 (-1.05%)

16:33
07/16/18
07/16
16:33
07/16/18
16:33
Hot Stocks
Nasdaq schedules hearing to consider Neovasc's appeal of delisting »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$24.39

-0.5 (-2.01%)

16:32
07/16/18
07/16
16:32
07/16/18
16:32
Hot Stocks
International Game announces FanDuel sports betting agreement »

International Game…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.